Navigation Links
Boston Scientific Welcomes Progress on Pain Care Legislation
Date:6/23/2008

is press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward- looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

CONTACT: Paul Donovan

508-650-8541 (office)

508-667-5165 (mobile)

Media Relations

Boston Scientific Corporation

Larry Neumann

508-650-8696 (office)

Investor Relations

Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces New Initiatives to Increase Shareholder Value
7. Boston Scientific Announces Additions to Clinical Sciences Organization
8. Boston University School of Medicine physician receives award from AATOD
9. Boston Scientific Announces Verdict in Cordis Litigation
10. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , NEW YORK, Dec. 4 Thousands ...0 offices nationwide today, to participate in a co...x and advisory firm,s support for literacy with ch... reflects our firm,s long history of volunteerism....d in the spirit of caring to brighten the holidays...
(Date:12/4/2009)..., SCOTTSDALE, Ariz., Dec. 4 Hea...aged, non-traded, real estate investment trust, an...ment to acquire a three building medical office po...exas, and Fort Wayne, Indiana for approximately $2...ect to the satisfaction of a number of conditions....
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ ...rm would control health care costs, Leapfrog,s pur...ough example -- delivering the best quality care i... efficiency. Thirty-four urban, eight children,s a...frog Top Hospitals, based on results from The Leap...
(Date:12/4/2009)...king with mice, scientists at Johns Hopkins publis...wn that a protein made by a gene called "Twist" ma...istinguish stem cells that drive aggressive, metas.... , Building on recent work suggesting that it i...st tumors that drives breast cancer, scientists ha...
(Date:12/4/2009)... Dental tourism is a phenomenon ...n alternative to the high price of dental work in ...ch for lower priced dental care, people have found... a dental tourist destination. , ... business for more than 6 years, Mexican Dental Va...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
...c. 2 Global Med Technologies(R), Inc.,("Global Me...n international,e-Health, medical information tech...subsidiary, Inlog S.A., has licensed its EdgeTrack...tient beds. For,Global Med, this project represent...
...twork of Peers, Parents and Professionals Shares E...tion, Employment, Recreation, More , , WASHIN...isability association working on equity, diversity...cessible to people with disabilities, family membe...
...tasimelteon show it could aid shift workers, peopl...(HealthDay News) -- The experimental drug tasimelt...ag or night shifts, according to the results of tw...n, or a placebo. They were monitored for seven nig...
...la., Dec. 2 MEDai, Inc., headquartered in,Orlando... added a new module,to its existing suite of predi...ule monitors a population,s compliance to evidence...provides,real-time decision support at point of ca...
...veals Nearly Half Have Skipped Medical Care Due to...ew survey released today by the National Women,s H...roubling aspect of the current financial crisis: m... gotten worse over the past five years and that th...
...a., Dec. 2 Arlington Medical Resources (AMR), a,p...rmaceutical and diagnostic,imaging industries, fin...quin,is the preferred quinolone antibiotic among m...act infections caused by,numerous bacterial pathog...
Other Medicine News:Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 2Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 3Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 4Health News:New Website Links People With Disabilities to Peers for Help 2Health News:Drug Effective for Temporary Sleep Disruptions 2Health News:MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care 2Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4Health News:Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States 2
(Date:12/4/2009)... Dec. 4 Thermographic Diagnostic I...er in Marlton, New Jersey continues to provide sup...omuscular system, thyroid, dental, TMJ and sinus r...s associated with these areas. ,, Thermography... entire infrared range of the electromagnetic spec...
(Date:12/4/2009)...c. 4 Oxygen Biotherapeut...ed that the first patient has been enrolled in the...rial in Switzerland for use of Oxycyte(TM) emulsio...Company,s perfluorocarbon (PFC) therapeutic oxygen...tance in improving the outcome of patients with se...
(Date:12/4/2009)...LAKE FOREST, Ill., Dec. 4 /PRNewswire-FirstCall/ -...pecialty pharmaceutical and medication delivery co...ration 50 mL and 100 mL VisIV(TM) containers for i...ow offers a complete size range (50 mL to 1 L) of ...IV product. The launch of the 50 mL and 100 mL con...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Champions Biotechnology Partners with Do Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft 28TM 29 Testing 13061 1Champions Biotechnology Partners with Do Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft 28TM 29 Testing 13061 2Champions Biotechnology Partners with Do Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft 28TM 29 Testing 13061 3Champions Biotechnology Partners with Do Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft 28TM 29 Testing 13061 4U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 1U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 2U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 3U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 4Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 1Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 2Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 3
...Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced ...nc. (Ortho-McNeil) initiated under their partnersh...97, a novel oral drug candidate discovered by Aren...c receptor (GDIR) for the treatment of type 2 diab...s the potential to stimulate insulin release in re...
... 14 Eisai Corporation of North,America today anno...FDA) has,approved LUSEDRA(TM) (fospropofol disodiu...nt for monitored anesthesia care (MAC) sedation in...ic procedures. , In the approval, the FDA re...d in the administration of general anesthesia and ...
Other Medicine Technology:Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 2Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 3Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 4FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 2FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 3FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 4
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: